153 related articles for article (PubMed ID: 27307760)
1. The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia.
Sychev DA; Shuev GN; Chertovskih JV; Maksimova NR; Grachev AV; Syrkova OA
Pharmgenomics Pers Med; 2016; 9():59-63. PubMed ID: 27307760
[TBL] [Abstract][Full Text] [Related]
2. Statin-induced myopathy SLCO1B1 521T > C is associated with prediabetes, high body mass index and normal lipid profile in Emirati population.
Saber-Ayad M; Manzoor S; El-Serafi A; Mahmoud I; Abusnana S; Sulaiman N
Diabetes Res Clin Pract; 2018 May; 139():272-277. PubMed ID: 29534995
[TBL] [Abstract][Full Text] [Related]
3. Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.
Hou Q; Li S; Li L; Li Y; Sun X; Tian H
Medicine (Baltimore); 2015 Sep; 94(37):e1268. PubMed ID: 26376374
[TBL] [Abstract][Full Text] [Related]
4. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
[TBL] [Abstract][Full Text] [Related]
5. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
[TBL] [Abstract][Full Text] [Related]
6. SLCO1B1 c.521T>C Genotyping in the Austrian Population Using 2 Commercial Real-Time Polymerase Chain Reaction Assays: An Implementation Study.
Enko D; Harringer S; Oberkanins C; Pühringer H; Halwachs-Baumann G; Kriegshäuser G
Pharmacology; 2018; 102(1-2):88-90. PubMed ID: 29969773
[TBL] [Abstract][Full Text] [Related]
7. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
[TBL] [Abstract][Full Text] [Related]
9. SLCO1B1 Gene Polymorphisms (rs2306283 and rs4149056) and Statin-Induced Myopathy in Jordanian Diabetics.
Shahrure ZM; Irshaid YM; Mustafa KN; Abujbara MA; Al Shhab M; El-Khateeb MS; Ajlouni KM
Curr Rev Clin Exp Pharmacol; 2021; 16(3):281-288. PubMed ID: 32860365
[TBL] [Abstract][Full Text] [Related]
10. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
Ramakumari N; Indumathi B; Katkam SK; Kutala VK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
[TBL] [Abstract][Full Text] [Related]
11. SLCO1B1 Polymorphisms and Statin-Induced Myopathy.
Stewart A
PLoS Curr; 2013 Dec; 5():. PubMed ID: 24459608
[TBL] [Abstract][Full Text] [Related]
12. SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.
Santos PC; Soares RA; Nascimento RM; Machado-Coelho GL; Mill JG; Krieger JE; Pereira AC
BMC Med Genet; 2011 Oct; 12():136. PubMed ID: 21992719
[TBL] [Abstract][Full Text] [Related]
13. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.
Carr DF; O'Meara H; Jorgensen AL; Campbell J; Hobbs M; McCann G; van Staa T; Pirmohamed M
Clin Pharmacol Ther; 2013 Dec; 94(6):695-701. PubMed ID: 23942138
[TBL] [Abstract][Full Text] [Related]
14. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
[TBL] [Abstract][Full Text] [Related]
15. SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.
Prado Y; Saavedra N; Zambrano T; Lagos J; Rosales A; Salazar LA
Int J Mol Sci; 2015 Aug; 16(9):20609-19. PubMed ID: 26334272
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients.
Toms TE; Smith JP; Panoulas VF; Douglas KM; Saratzis AN; Kitas GD
Musculoskeletal Care; 2010 Mar; 8(1):2-9. PubMed ID: 19642078
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins.
Dou Y; Zhu X; Wang Q; Tian X; Cheng J; Zhang E
Ann Lab Med; 2015 May; 35(3):329-35. PubMed ID: 25932441
[TBL] [Abstract][Full Text] [Related]
18. Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China.
Zhong Z; Wu H; Li B; Li C; Liu Z; Yang M; Zhang Q; Zhong W; Zhao P
J Clin Lab Anal; 2018 Jul; 32(6):e22408. PubMed ID: 29424099
[TBL] [Abstract][Full Text] [Related]
19. SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability.
Zubiaur P; Benedicto MD; Villapalos-García G; Navares-Gómez M; Mejía-Abril G; Román M; Martín-Vílchez S; Ochoa D; Abad-Santos F
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33805706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
